Immatics (IMTX) Operating Leases (2019 - 2025)
Immatics (IMTX) reported Operating Leases of $15.0 million for Q4 2025, up 5.06% on a YoY basis from $14.3 million in Q4 2024, and down 5.02% sequentially from $15.8 million in Q3 2025.
Immatics (IMTX) Operating Leases (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Operating Leases data on file, last reported at $15.0 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Leases rose 5.06% year-over-year to $15.0 million; the trailing twelve-month figure through Dec 2025 stood at $15.0 million (up 5.06% YoY), and the FY2025 full-year result was $14.5 million, up 0.68% from the prior year.
- Operating Leases retreated to $15.0 million in Q4 2025, from $15.8 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $16.1 million in Q1 2025 to a low of $5.2 million in Q3 2021.
- A 5-year average of $12.5 million and a median of $14.1 million in 2022 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases fell 9.22% in 2021 and jumped 169.38% in 2022, its largest moves.
- Tracing IMTX's Operating Leases over 5 years: stood at $8.2 million in 2021, then soared by 54.88% to $12.7 million in 2022, then advanced by 8.82% to $13.8 million in 2023, then grew by 3.62% to $14.3 million in 2024, then advanced by 5.06% to $15.0 million in 2025.
- Business Quant data shows IMTX's Operating Leases at $15.0 million in Q4 2025, $15.8 million in Q3 2025, and $16.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.99 Mn |
| Sep 30, 2025 | 15.78 Mn |
| Jun 30, 2025 | 15.97 Mn |
| Mar 31, 2025 | 16.14 Mn |
| Dec 31, 2024 | 14.27 Mn |
| Sep 30, 2024 | 14.49 Mn |
| Jun 30, 2024 | 15.33 Mn |
| Mar 31, 2024 | 12.90 Mn |
| Dec 31, 2023 | 13.77 Mn |
| Sep 30, 2023 | 14.88 Mn |
| Jun 30, 2023 | 15.34 Mn |
| Mar 31, 2023 | 13.43 Mn |
| Dec 31, 2022 | 12.65 Mn |
| Sep 30, 2022 | 13.97 Mn |
| Jun 30, 2022 | 14.92 Mn |
| Mar 31, 2022 | 7.29 Mn |
| Dec 31, 2021 | 8.17 Mn |
| Sep 30, 2021 | 5.19 Mn |
| Jun 30, 2021 | 5.70 Mn |
| Mar 31, 2021 | 5.28 Mn |